PF-07293893

DRUG3 trials

Sponsors

Pfizer

Conditions

Healthy Participants

Phase 1

A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults

CompletedNCT05907395

PfizerHealthy Participants

Start: 2023-08-09End: 2024-03-22Updated: 2025-04-10

A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult Participants

CompletedNCT06177457

PfizerHealthy Participants

Start: 2023-12-20End: 2024-12-02Updated: 2024-12-18

A STUDY TO LEARN HOW THE STUDY MEDICINE CALLED PF-07293893 AFFECTS MUSCLE BIOMARKERS OF HEALTHY ADULTS

CompletedNCT06413693

PfizerHealthy Participants

Start: 2024-05-23End: 2024-08-05Updated: 2024-11-20